Gene Silencing-Biotech ADARx Makes Some Noise With $535M Stock Market Debut

ADARx Pharmaceuticals upsized its IPO and raised additional cash through a private placement with partner AbbVie. Lead ADARx program onvuzosiran is in Phase 3 testing for the rare disease hereditary angioedema, and the RNA therapies pipeline also spans immunological disorders, cardiovascular diseases and obesity, and neurodegeneration. The post Gene Silencing-Biotech ADARx Makes Some Noise With…

Read More

HealthEx — The Demo with Claude & the CEO Speaks!

I spent some time figuring out and getting a little help in uploading my health records to Claude, using HealthEx. I did the demo with Ruheed Mohamed, the head of technical services, and then I interviewed CEO Priyanka Agarwal, MD. This shows how Healthex gets data and incorporates it into Claude, and where Priyanka thinks…

Read More